Who is sponsoring NCT05376787?

NCT05376787 is sponsored by Medline Industries.

What drugs are being tested in NCT05376787?

Interventions in NCT05376787: Medline NE Grounding Pad.

What condition does NCT05376787 study?

NCT05376787 studies Adhesion of the Neutral Electrode 21pad.

Is NCT05376787 still recruiting?

NCT05376787 is currently completed. Last updated 17 October 2024.

Are results published for NCT05376787?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-10-17 · How we verify

NCT05376787

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Verify the Performance of the Neutral Electrode (NE) Adhesives

Completed Results posted Last updated 17 October 2024

What this trial tests

trial testing Medline NE Grounding Pad in Adhesion of the Neutral Electrode 21pad in 20 participants. Completed in 10 June 2022.

Timeline

30 May 2022

Primary endpoint
10 June 2022

10 June 2022

Quick facts

Lead sponsor	Medline Industries
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	30 May 2022
Primary completion	10 June 2022
Estimated completion	10 June 2022
Sites	1 location across United States

Drugs / interventions tested

Medline NE Grounding Pad

Conditions studied

Adhesion of the Neutral Electrode 21pad — all drugs for Adhesion of the Neutral Electrode 21pad →

Sponsor

Medline Industries — full company profile →

Who can join

Eligibility, any sex, with Adhesion of the Neutral Electrode 21pad. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Tests With No More Than 5% Separation - Neutral Electrode (NE) Adhesive Separation Primary · Up to 20 minutes - (10 minutes w. Pull for 10 to 10.25 minutes, in a plane parallel to the NE pad & At 10 mins, change direction of pull to y direction)

To determine the percentage of adhesion separation by only measuring test results that had no more than 5% of the NE adhesive area separated. At Point A where the NE connects to the pad, connect a cord to pull on the cable. Pull for 10 to 10.25 minutes, in a plane parallel to the NE pad and in a direction away from the center of the pad, with 10 to 11N (1.02 to 1.12kg) of force in the direction along the minor dimension of the pad. Set the height of the pulley so that the direction of pull shall be approximately co-planer with the plane of the connection point of the NE. The pull shall be per

Group	Value	95% CI
Healthy Subjects	39

Sponsor's own description

The purpose of this research study is to determine the neutral electrode 21pad adhesion to the skin in accordance with international standard IEC 60601-2-2 section 201.15.101.7. A neutral electrode is placed on the body of patients undergoing surgery that involves the use of electric current, to protect them from the harmful effects of the electricity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Medline Industries trials

Trials by the same sponsor.

NCT05755282 — Touch and Feel Evaluation of Two Foam Hand Sanitizers · Phase 4 · completed
NCT05740332 — Wet Time for a Foam Hand Sanitizer · Phase 4 · completed
NCT05756348 — Durability of Two Skin Barrier Protectants (SBP) · NA · completed
NCT05742347 — Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions · NA · terminated
NCT05250102 — Neonatal Pulse Oximetry Sensor Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05376787 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medline Industries
Last refreshed: 17 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05376787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing